Tokyo, March 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060242) titled 'Effects of Additional Spironolactone on Persistent Proteinuria After SGLT2 Inhibitor Therapy in Patients with Diabetic Kidney Disease' on March 1.
Study Type:
Observational
Primary Sponsor:
Institute - Jinnouchi Hospital
Condition:
Condition - Type-2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - spironolactone therapy-induced changes in urinary protein-to-creatinine ratio (UPCR) levels
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - stable adult T2DM patients demonstrated persist...